Lecture 5: Regulation of Pharmacoepidemiology Research Flashcards

1
Q

What was the significance of the FDA amendment act (FDAAA) of 2007?

A

1) Increased authority to require postmarketing studies and/or clinical trials
2) authority to require changes to drug labeling
3) Mandate to develop guidance on best practices for epi studies
4) Mandate to develop a new post-market risk identification and analysis system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of observational epidemiological studies that FDA may require

A

1) Assess a serious risk associated with a drug exposure or to quantify risk or evaluate factors that affect the risk of serious toxicity (eg, drug dose, timing of exposure, or patient characteristics)
2) examine natural history of a disease or to estimate background rates for adverse events in a population not treated wth the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

FDA postmarking study requirements

A

1) Develop study protocol (analytic study or descriptive study)
2) Must submit periodic reports on status, including any challenges to meeting study timelines
3) Non-compliance may result in financial penalties and/or drug distribution limitations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define Comparative effectiveness research

A
  • Research that provides evidence on the effectiveness, benefits and harms of different treatment options.
  • Evidence is generated from studies that compare drugs, medical devices, tests, surgeries or ways to deliver health care
  • Designed to inform health care decisions such as reimbursement.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

US Pubic disclosure requirements

A

There is currently no US legal requirement to disclose non interventional studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

EU definition of non-interventional study

A

A study where: the medicinal products are prescribed in the usual manner in accordance with the terms of the marketing authorization
Note that the assignment of a patient to a particular therapeutic strategy is not decided in advance by a trial protocol, but falls within the current practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

EU definition of low interventional clinical trial

A

A study where: the investigational medicinal product is authorized. Assignment to a particular therapeutic strategy is decided in advance by a trial protocol and taken together with the decision to include the patient (ex. LST)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Post Authorization safety studies (PASS)

A

Imposed as a condition of or following marketing authorization
Includes non-interventional (observational) and interventional studies (involves randomization)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Post Authorization efficacy studies (PAES)

A
  • Complements the data available at the time of authorization with additional information concerning the efficacy of a medicinal product.
  • addresses concerns that could not be resolved prior to market authorization
  • European commission empowered to require PAES
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ENCePP Guidance

A

European Network of centers for pharmacoepi and pharmacovigilance: a collaborated scientific network coordinated by the EMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ISPE guidance

A

International Society for Pharmacoepidemiology provides guidelines for pharmacoepi practices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly